Shattuck Labs IncNASDAQ:STTK
- LAST PRICE3.8600
- TODAY'S CHANGE (%)0.1100 (2.9333%)
- Bid / Lots3.8600/ 1
- Ask / Lots3.9500/ 14
- Open / Previous Close3.7600 / 3.7500
- Day Range
- 52 Week Range
- Volume6,403,816
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STTK |
|---|---|---|
| 09:32 ET | 50203 | 3.76 |
| 09:34 ET | 47893 | 3.72 |
| 09:45 ET | 10500 | 3.7 |
| 09:48 ET | 5052 | 3.72 |
| 09:50 ET | 500 | 3.765 |
| 09:52 ET | 100 | 3.79 |
| 09:54 ET | 1306 | 3.82 |
| 09:56 ET | 1550 | 3.8 |
| 09:57 ET | 300 | 3.79 |
| 09:59 ET | 900 | 3.78 |
| 10:01 ET | 635 | 3.76 |
| 10:03 ET | 3675 | 3.78 |
| 10:06 ET | 8071 | 3.8 |
| 10:08 ET | 600 | 3.8 |
| 10:10 ET | 1100 | 3.8 |
| 10:12 ET | 900 | 3.8 |
| 10:14 ET | 11069 | 3.89 |
| 10:15 ET | 16363 | 3.88 |
| 10:17 ET | 2009 | 3.92 |
| 10:19 ET | 697 | 3.94 |
| 10:21 ET | 1125 | 3.93 |
| 10:24 ET | 5174 | 3.98 |
| 10:26 ET | 900 | 3.965 |
| 10:28 ET | 5115 | 3.94 |
| 10:30 ET | 3201 | 3.96 |
| 10:32 ET | 11215 | 3.9 |
| 10:33 ET | 900 | 3.9 |
| 10:35 ET | 600 | 3.9 |
| 10:37 ET | 5124 | 3.82 |
| 10:39 ET | 4674 | 3.83 |
| 10:42 ET | 500 | 3.83 |
| 10:44 ET | 500 | 3.85 |
| 10:46 ET | 3423 | 3.875 |
| 10:48 ET | 2254 | 3.89 |
| 10:50 ET | 100 | 3.9 |
| 10:51 ET | 400 | 3.91 |
| 10:53 ET | 2300 | 3.89 |
| 10:55 ET | 3198 | 3.88 |
| 10:57 ET | 900 | 3.88 |
| 11:00 ET | 1400 | 3.895 |
| 11:02 ET | 800 | 3.88 |
| 11:04 ET | 2387 | 3.89 |
| 11:06 ET | 2315 | 3.9 |
| 11:08 ET | 5535 | 3.87 |
| 11:09 ET | 500 | 3.87 |
| 11:11 ET | 1100 | 3.87 |
| 11:13 ET | 400 | 3.87 |
| 11:15 ET | 400 | 3.87 |
| 11:18 ET | 825 | 3.89 |
| 11:20 ET | 3156 | 3.88 |
| 11:22 ET | 700 | 3.9 |
| 11:24 ET | 1100 | 3.88 |
| 11:26 ET | 3050 | 3.91 |
| 11:27 ET | 500 | 3.9 |
| 11:29 ET | 800 | 3.9 |
| 11:31 ET | 18157 | 3.85 |
| 11:33 ET | 1000 | 3.85 |
| 11:36 ET | 600 | 3.85 |
| 11:38 ET | 17570 | 3.82 |
| 11:40 ET | 2600 | 3.78 |
| 11:42 ET | 4443 | 3.81 |
| 11:44 ET | 800 | 3.81 |
| 11:45 ET | 3492 | 3.83 |
| 11:47 ET | 2272 | 3.85 |
| 11:49 ET | 1325 | 3.83 |
| 11:51 ET | 1300 | 3.83 |
| 11:54 ET | 2202 | 3.86 |
| 11:56 ET | 1208 | 3.84 |
| 11:58 ET | 8645 | 3.85 |
| 12:00 ET | 850 | 3.85 |
| 12:02 ET | 1200 | 3.85 |
| 12:03 ET | 1000 | 3.86 |
| 12:05 ET | 52953 | 3.82 |
| 12:07 ET | 5431 | 3.82 |
| 12:09 ET | 1177 | 3.8 |
| 12:12 ET | 1100 | 3.81 |
| 12:14 ET | 3486 | 3.795 |
| 12:16 ET | 600 | 3.78 |
| 12:18 ET | 1517 | 3.775 |
| 12:20 ET | 400 | 3.76 |
| 12:21 ET | 9429 | 3.79 |
| 12:23 ET | 100 | 3.79 |
| 12:25 ET | 2975 | 3.81 |
| 12:27 ET | 1200 | 3.82 |
| 12:30 ET | 6729 | 3.83 |
| 12:32 ET | 1000 | 3.83 |
| 12:34 ET | 800 | 3.84 |
| 12:36 ET | 1000 | 3.83 |
| 12:38 ET | 10233 | 3.84 |
| 12:39 ET | 3441 | 3.84 |
| 12:41 ET | 4239 | 3.85 |
| 12:43 ET | 400 | 3.85 |
| 12:45 ET | 800 | 3.85 |
| 12:48 ET | 1852 | 3.84 |
| 12:50 ET | 1214 | 3.84 |
| 12:52 ET | 680 | 3.845 |
| 12:54 ET | 1181 | 3.84 |
| 12:56 ET | 6091 | 3.87 |
| 12:57 ET | 800 | 3.85 |
| 12:59 ET | 925 | 3.86 |
| 01:01 ET | 5703 | 3.86 |
| 01:03 ET | 1200 | 3.86 |
| 01:06 ET | 2128 | 3.86 |
| 01:08 ET | 5483 | 3.86 |
| 01:10 ET | 1500 | 3.875 |
| 01:12 ET | 612 | 3.875 |
| 01:14 ET | 4130 | 3.86 |
| 01:15 ET | 2941 | 3.86 |
| 01:17 ET | 2775 | 3.86 |
| 01:19 ET | 2585 | 3.85 |
| 01:21 ET | 17998 | 3.8 |
| 01:24 ET | 4082 | 3.77 |
| 01:26 ET | 1967 | 3.74 |
| 01:28 ET | 4116 | 3.71 |
| 01:30 ET | 8378 | 3.755 |
| 01:32 ET | 1232 | 3.75 |
| 01:33 ET | 5744 | 3.74 |
| 01:35 ET | 2132 | 3.75 |
| 01:37 ET | 1386 | 3.74 |
| 01:39 ET | 8749 | 3.76 |
| 01:42 ET | 17573 | 3.8 |
| 01:44 ET | 6542 | 3.8 |
| 01:46 ET | 730 | 3.82 |
| 01:48 ET | 6870 | 3.81 |
| 01:50 ET | 4791 | 3.8 |
| 01:51 ET | 4587 | 3.8 |
| 01:53 ET | 30496 | 3.805 |
| 01:55 ET | 2699 | 3.79 |
| 01:57 ET | 6213 | 3.8 |
| 02:00 ET | 1208 | 3.78 |
| 02:02 ET | 1400 | 3.77 |
| 02:04 ET | 15932 | 3.81 |
| 02:06 ET | 3900 | 3.82 |
| 02:08 ET | 4250 | 3.82 |
| 02:09 ET | 4025 | 3.81 |
| 02:11 ET | 3930 | 3.81 |
| 02:13 ET | 1710 | 3.81 |
| 02:15 ET | 3021 | 3.815 |
| 02:18 ET | 1600 | 3.8 |
| 02:20 ET | 1706 | 3.8 |
| 02:22 ET | 27814 | 3.84 |
| 02:24 ET | 3025 | 3.87 |
| 02:26 ET | 800 | 3.87 |
| 02:27 ET | 7999 | 3.87 |
| 02:29 ET | 1670 | 3.86 |
| 02:31 ET | 2241 | 3.85 |
| 02:33 ET | 1170 | 3.83 |
| 02:36 ET | 1980 | 3.83 |
| 02:38 ET | 11637 | 3.86 |
| 02:40 ET | 435 | 3.86 |
| 02:42 ET | 2856 | 3.84 |
| 02:44 ET | 2000 | 3.83 |
| 02:45 ET | 1165 | 3.81 |
| 02:47 ET | 6139 | 3.8 |
| 02:49 ET | 15551 | 3.81 |
| 02:51 ET | 1100 | 3.81 |
| 02:54 ET | 995 | 3.8 |
| 02:56 ET | 1196 | 3.8 |
| 02:58 ET | 2191 | 3.8 |
| 03:00 ET | 1480 | 3.8 |
| 03:02 ET | 2885 | 3.8 |
| 03:03 ET | 6459 | 3.8 |
| 03:05 ET | 3431 | 3.8 |
| 03:07 ET | 3999 | 3.8 |
| 03:09 ET | 4928 | 3.8 |
| 03:12 ET | 5399 | 3.8 |
| 03:14 ET | 4258 | 3.8 |
| 03:16 ET | 6702 | 3.8 |
| 03:18 ET | 2500 | 3.8 |
| 03:20 ET | 4833 | 3.8 |
| 03:21 ET | 2509 | 3.81 |
| 03:23 ET | 6982 | 3.805 |
| 03:25 ET | 1711 | 3.8 |
| 03:27 ET | 15825 | 3.8 |
| 03:30 ET | 10374 | 3.8 |
| 03:32 ET | 3907 | 3.795 |
| 03:34 ET | 10832 | 3.8 |
| 03:36 ET | 6574 | 3.8 |
| 03:38 ET | 11886 | 3.84 |
| 03:39 ET | 4075 | 3.83 |
| 03:41 ET | 4316 | 3.84 |
| 03:43 ET | 2424 | 3.86 |
| 03:45 ET | 15246 | 3.85 |
| 03:48 ET | 1799 | 3.86 |
| 03:50 ET | 12560 | 3.85 |
| 03:52 ET | 39676 | 3.92 |
| 03:54 ET | 6464 | 3.93 |
| 03:56 ET | 56087 | 3.88 |
| 03:57 ET | 41463 | 3.88 |
| 03:59 ET | 4058216 | 3.86 |
Jun 20, 2024
DJ Shattuck Labs Is Maintained at Buy by HC Wainwright & Co., from 6:32AM ET on Thursday Jun 20, 2024 by Dow Jones
6:32AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 17, 2024
DJ Shattuck Labs Is Maintained at Buy by Citigroup, from 11:04AM ET on Monday Jun 17, 2024 by Dow Jones
11:04AM ET on Monday Jun 17, 2024 by Dow Jones
Jun 14, 2024
DJ Shattuck Labs Is Maintained at Buy by Needham, from 12:01PM ET on Friday Jun 14, 2024 by Dow Jones
12:01PM ET on Friday Jun 14, 2024 by Dow JonesShattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients, from 6:00AM ET on Friday Jun 14, 2024 by Dow Jones
6:00AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 10, 2024
DJ Shattuck Labs Gets FDA's Orphan Drug Status for Leukemia Treatment, from 8:04AM ET on Monday Jun 10, 2024 by Dow Jones
8:04AM ET on Monday Jun 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Shattuck Labs Inc | 183.5M | -2.0x | --- |
Candel Therapeutics Inc | 184.5M | -4.8x | --- |
Acrivon Therapeutics Inc | 179.1M | -2.0x | --- |
Immutep Ltd | 284.8M | -7.7x | --- |
bluebird bio Inc | 187.3M | -1.3x | --- |
Design Therapeutics Inc | 189.3M | -3.2x | --- |
Company Information
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Contact Information
- Headquarters
- 500 W. 5Th Street, Suite 100AUSTIN, TX, United States 78701
- Phone
- 512-900-4690
- Fax
- ---
Executives
- Independent Chairman of the Board
- George Golumbeski
- Chief Executive Officer, Co-Founder, Director
- Taylor Schreiber
- Chief Financial Officer
- Andrew Neill
- General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
- Stephen Stout
- Chief Business Officer
- Casi Deyoung
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $183.5M |
|---|---|
Revenue (TTM) | $2.7M |
Shares Outstanding | 47.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.72 |
EPS | $-1.93 |
Book Value | $3.06 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 67.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,327.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
